WASHINGTON:
Are you looking for permanent freedom from smoking? Try these new potential drugs to quit smoking.
Researchers at Washington State University created more than a dozen candidate drugs with the potential to curb smokers’ desire for nicotine by slowing how it is broken down in the body. They hoped that the substances could help people reduce their consumption of tobacco, if not quit altogether.
The discovery targets a liver enzyme, called CYP2A6, which metabolizes nicotine. Researchers found that people who have fewer copies of a gene for the enzyme tend to smoke less and are less likely to be addicted to smoking.
Nicotine triggers the release of dopamine and serotonin, two pleasure-causing chemicals produced by the body. But as it gets metabolized, users can experience withdrawal symptoms like tingling in the hands and feet, sweating, anxiety, and irritability.
They also designed dozens of molecules that bind to CYP2A6 and inhibit its ability to metabolize nicotine.
“If you inhibit CYP2A6, it shouldn’t bother your overall health. If we could specifically target this enzyme, people should be fine, and it will possibly help them stop smoking or at least decrease their amount of smoking,” said Philip Lazarus, co-author of the study.
So far, the researchers have tested their candidate drugs to make sure they don’t disrupt other major enzymes that help the body metabolize other substances. This helped narrow the number of potential drugs down to 18.
The findings appeared in the Journal of Medicinal Chemistry. (ANI)
more recommended stories
BRICS Playing Bigger Role in New World Economic OrderNEW DELHI:India’s 2026 BRICS Presidency offers.
India’s Indigenous Bullet Train Trials to Start by May-June Next Year: Ashwini VaishnawNEW DELHI:India’s first indigenously developed bullet.
Trump Backs New H-1B Fee in Labour Day Push to Prioritise US WorkersWASHINGTON:US President Donald Trump used his.
Aster Medcity and Wisdom4Future Initiative Made an Entire School Staff “First Responders of Kerala”KOZHIKODE:Vadi Husna Public School has become.
BRIC-RGCB Researchers Develop Novel Nanopore Sensors for Early Detection of Parkinson’s DiseaseTHIRUVANANTHAPURAM: Researchers at the BRIC-Rajiv Gandhi.
Aster Medcity Introduces Advanced Genetic Study that Detects Disease RiskKOCHI:Aster Medcity has launched the Aster.
Indian-American Teen Murders Mother, Brother in US HomeWASHINGTON:A 17-year-old Indian-American boy in Acton,.
Cancer Drug Weakens Deadly Pneumonia Pathogen, Says a RGCB StudyTHIRUVANANTHAPURAM:Scientists at the BRIC-Rajiv Gandhi Centre.
K’taka Bans Sale & Distribution of Tobacco, Nicotine Products for 1 YearBENGALURU:The Karnataka Department of Food Safety.
Veteran White House Reporter Breaks 26-Year Silence on Clinton’s 2000 Pakistan Decoy PlaneWASHINGTON:A veteran White House reporter has.

